JULIO BELARMINO
BOBES GARCIA


University of Palermo
Palermo, ItaliaPublications in collaboration with researchers from University of Palermo (37)
2025
-
Cannabis Use Cessation and the Risk of Psychotic Disorders: A Case–Control Analysis from the First Episode Case–Control EU-GEI WP2 Study: L’arrêt de l’utilisation du cannabis et le risque de troubles psychotiques: Une analyse cas-témoins tirée de l’étude cas-témoins EU-GEI WP2 centrée sur les premiers épisodes psychotiques
Canadian Journal of Psychiatry, Vol. 70, Núm. 3, pp. 182-193
-
Cognitive presentation at psychosis onset through premorbid deterioration and exposure to environmental risk factors
Psychological Medicine, Vol. 55
-
Methylomic signature of current cannabis use in two first-episode psychosis cohorts
Molecular Psychiatry, Vol. 30, Núm. 4, pp. 1277-1286
-
Variation of subclinical psychosis as a function of population density across different European settings: Findings from the multi-national EU-GEI study
Acta Psychiatrica Scandinavica, Vol. 151, Núm. 4, pp. 506-520
2024
-
Cannabis use and cognitive biases in people with first-episode psychosis and their siblings
Psychological Medicine
-
Self-reported suicidal ideation among individuals with first episode psychosis and healthy controls: Findings from the international multicentre EU-GEI study
Schizophrenia Research, Vol. 270, pp. 339-348
-
The Role of Social Deprivation and Cannabis Use in Explaining Variation in the Incidence of Psychotic Disorders: Findings From the EU-GEI Study
Schizophrenia Bulletin, Vol. 50, Núm. 5, pp. 1039-1049
-
The effect of polygenic risk score and childhood adversity on transdiagnostic symptom dimensions at first-episode psychosis: evidence for an affective pathway to psychosis
Translational Psychiatry, Vol. 14, Núm. 1
-
The impact of schizophrenia genetic load and heavy cannabis use on the risk of psychotic disorder in the EU-GEI case-control and UK Biobank studies
Psychological Medicine
-
Variation of subclinical psychosis across 16 sites in Europe and Brazil: findings from the multi-national EU-GEI study
Psychological medicine, Vol. 54, Núm. 8, pp. 1810-1823
2023
-
Cannabis use as a potential mediator between childhood adversity and first-episode psychosis: Results from the EU-GEI case-control study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7375-7384
-
Child maltreatment, migration and risk of first-episode psychosis: results from the multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 13, pp. 6150-6160
-
Development and Validation of Predictive Model for a Diagnosis of First Episode Psychosis Using the Multinational EU-GEI Case-control Study and Modern Statistical Learning Methods
Schizophrenia Bulletin Open, Vol. 4, Núm. 1
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
Exploring the mediation of DNA methylation across the epigenome between childhood adversity and First Episode of Psychosis—findings from the EU-GEI study
Molecular Psychiatry, Vol. 28, Núm. 5, pp. 2095-2106
-
Synergistic effects of childhood adversity and polygenic risk in first-episode psychosis: The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 5, pp. 1970-1978
-
The association between reasons for first using cannabis, later pattern of use, and risk of first-episode psychosis: the EU-GEI case-control study
Psychological medicine, Vol. 53, Núm. 15, pp. 7418-7427
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
-
Tobacco use in first-episode psychosis, a multinational EU-GEI study
Psychological Medicine, Vol. 53, Núm. 15, pp. 7265-7276
-
Use of multiple polygenic risk scores for distinguishing schizophrenia-spectrum disorder and affective psychosis categories in a first-episode sample; The EU-GEI study
Psychological Medicine, Vol. 53, Núm. 8, pp. 3396-3405